Virginia Catalyst’s next round of grant funding to focus on COVID-19 solutions
A nonprofit organization, Virginia Catalyst, has announced its 11th round of grant funding with an emphasis on ground-breaking projects focused on solutions for COVID-19 and other infectious diseases.
Michael Grisham, president and chief executive officer of the Richmond-based group, said they are encouraging research universities to work with industry to achieve breakthroughs.
“We expect the funding to support the development of novel vaccines, new diagnostic tools that provide monitoring and coaching for people who have the coronavirus, and new service delivery models including telehealth and telemedicine,” Grisham said in a statement.
Virginia Catalyst’s first 10 funding rounds enabled it to dedicate $19.1 million for 43 collaborative projects. The projects have created more than 170 new jobs and brought an additional $228 million of investment capital.
Created by the Virginia General Assembly, the organization is funded by the Commonwealth’s General Fund, Eastern Virginia Medical School, and several universities: George Mason; Old Dominion; University of Virginia; Virginia Commonwealth; Virginia Tech; and William & Mary.
To learn more, check out the whole article below.